A primary means of detecting and identifying specific proteins in cellular extracts is by Western blot analysis (4, 13) . Quantitation of a protein of interest is generally accomplished using an enzyme-linked immunosorbent assay (ELISA; References 8, 9 and 11) or radioimmunoassay (4, 8) . When ELISA or radioimmunoassay procedures for the protein of interest are unavailable, densitometric analysis of Western blots is often used to estimate the amount of antigen present (3) . However, quantitation of proteins on Western blots is subject to factors that limit the ability to accurately estimate the amount of the specific protein in the samples. These include variations in protein loading and loss of protein during electrophoretic transfer. Often, quantitation is performed on a single aliquot of the sample, with no indication of reproducibility of the result (3) . Slot-and dot-blotting techniques serve to overcome some of these limitations because multiple aliquots of the samples are directly applied to the membrane, eliminating the need for the transfer of protein (6) (7) (8) . Slot blotting is more conducive to accurate densitometric measurements than dot blotting and is generally preferable for work of a quantitative nature. However, quantitation by densitometric scanning has inherent limitations if care is not taken to ensure that the signals are within the linear range of response of the method of detection. This includes scanning of autoradiograms obtained using radioactive or luminescence-based detection reagents where all of the samples might not lie within the linear range of response of the photographic film. We have developed a slot-blot immunoassay to quantitate the amount of Aspergillus nidulans calcium/calmodulindependent multifunctional protein kinase (ACMPK) present in cell extracts of this filamentous fungus (1) . We describe the development of the assay and its use to detect the amount of ACMPK protein present in extracts prepared from cell cycle phase-specific and developmental phase-specific cultures of A. nidulans . Previous attempts to develop and perform ELISAs or quantify this protein by Western blot analysis have met with only limited success, as indicated by a high degree of variability from assay to assay. The use of the immuno-slot blot assay has yielded reproducible results, allowing for the quantitation of this protein in different cellular extracts.
Homogeneous cell cycle phase-specific cultures were prepared using A. nidulansstrain SO6 ( nimA5; w A2; y A2; cha A1; pyr G89; cnx E16; cho A1). A. nidulans strain SO6 carries the temperature-sensitive nimA5 mutation. Cells carrying the nimA5 mutation become blocked in late G2 phase at the restrictive temperature (42°C). Upon return to permissive temperature (32°C), cells enter mitosis within 5 min (2). Homogeneous G1-, S-, G2-and Mphase-specific SO6 cultures were prepared from cells that were initially grown for 16 h at the permissive temperature (32°C). S-phase cultures were prepared by shifting the cells to 42°C for 4 h and then transferring to medium containing 20 mM hydroxyurea for 90 min at 32°C. The G2-phase cells were shifted to 42°C for 4 h. M-phase cells were prepared by shifting cultures to 42°C for 4 h, followed by a 30-min incubation in 5 µ g/mL benomyl at 32°C to block cells in mitosis. The G1-phase culture was prepared by shifting cells to 42°C for 4 h and then transferring to 32°C for 15 min.
We were also interested in measuring ACMPK protein levels during the process of conidial germination and mycelial growth in A. nidulans . R153 ( w A2; pyro A4) conidia were inoculated into 500 mL defined medium containing 0.2% Tween ® 20 to a final concentration of 2.0 ×10 7 /mL. The conidia were allowed to germinate, and the culture was incubated for 16 h at 37°C with shaking. Samples were collected at set time points (2, 3, 4, 6, 8, 10, 12, 14 and 16 h). During this time period, A. nidulanscells developed from uninucleate conidia to long-branched, multinucleate mycelia (12) .
Cell extracts were next prepared as follows: (i) frozen cells were ground in a mortar with a pestle in liquid nitrogen and 2 mL/g tissue of 25 mM Tris-HCl, pH 8.0, 15 mM EDTA, 0.2% Nonidet ® P-40 (NP40), 1 mM diisopropylfluorophosphate, 10 µ g/mL leupeptin; (ii) homogenates were centrifuged at 14 000 ×gfor 15 min at 4°C; (iii) the pellets were discarded; and (iv) the extracts were stored at -90°C. Protein content of all samples was determined by the method of Schaffner and Weissmann (10) . Cell extracts were assayed for ACMPK protein using the immunoslot blot protocol developed. Aliquots of cell extracts were diluted with 100 µ g/mL bovine serum albumin (BSA) to a final volume of 300 µ L. For each ex - Under the conditions of the assay described above, the response is linear with logarithmic increases in dose. Regression analysis of the data obtained for the standard curve was performed using SigmaPlot ® Scientific Graphing System Version 5.00 (SPSS, Chicago, IL, USA) and the results presented in Figure 1 . All points on the curve fall within the 95% confidence limit. An r of 0.961 and a coefficient of variation of 0.92 were calculated for the standard curve using the Statview ® 512+ program (Abacus Concepts, Berkeley, CA, USA). The sensitivity as measured by the least detectable dose that yields a positive number within the 95% confidence limit is 5 ng.
The amount of ACMPK protein in the cell cycle stage-specific extract samples was determined by comparing values obtained over a 20-fold range of concentrations for each sample with the ACMPK standard curve. The results of three independent assays are reported with corresponding standard deviations in parentheses in Table 1 . Only those determinations that fell between 5 and 100 ng ACMPK on the standard curve (Figure 1) were used in the calculation of ACMPK content. The use of multiple aliquots containing a wide range of protein concentrations ensures that more than one determination will fall within this range. The intra-assay coefficients of variation calculated from the standard deviations ranged from 2.8% to 16.3% with a mean of 8.9%. The inter-assay coefficients of variation ranged from 0.6% to 10% with a mean of 4.2%. The highest concentration of ACMPK was found in M-phase cell extracts, which contained more than threefold higher kinase concentrations than the other samples. There was no significant difference in ACMPK content in extracts prepared from cells in G1, S and G2.
The immuno-slot blot protocol was also used to measure ACMPK protein during the process of conidial germination and mycelial growth in A. nidulans . Aliquots of R153 extract were collected at different stages of development and treated as described above. Samples containing 30 and 100 µ g soluble protein were assayed in duplicate. The immuno-slot blot protocol followed was identical to the one used for the cell cycle phase-specific extracts. ACMPK protein levels were shown to vary throughout the development of A. nidulans(i.e., from uninucleate conidia to branched mycelia [ Figure 2] ). The expression of ACMPK appears to be regulated temporally. There is a small but significant increase at 10 h and an approximately 4-fold increase between 12 and 14 h with a comparable decrease between 14 and 16 h. This pattern of ACMPK expression parallels kinase activity in these extracts (data not shown).
The immuno-slot blot protocol was successfully used to demonstrate that ACMPK varies both throughout development and in a cell cycle phasespecific manner in A. nidulansat the level of protein concentration. The immunoassay described above provides a sensitive, nonradioactive method for analyzing specific proteins in cellular samples. It is easy to perform and allows many samples to be analyzed simultaneously. More importantly, it Detection and quantitation of tumor necrosis factor (TNF)-αproduced in a number of clinical conditions or from cells in culture are very important for our understanding of many disease processes. TNF-αenzyme-linked immunosorbent assays (ELISAs) and bioassays are available. Current TNF-α bioassays are based on the cytolytic effects of bioactive TNF-αtrimer on responsive cell lines such as L929. Cytolysis has been routinely measured by crystal violet staining in a colorimetric assay (2) . Commercially available TNF-αELISAs are simple and sensitive (<10 pg/mL) but expensive. On the other hand, TNF-αbioassay protocols require cell culture and are generally inexpensive but problematic. We experienced difficulty with crystal violet staining and washing of the L929 indicator cells in standard TNF-αbioassay protocols. This difficulty often led to inconsistent and inaccurate results because residual dye remained, or stained live cells were accidently removed. XTT can be used in a colorimetric assay to measure both cell proliferation and cell lysis because it relies on cell mitochondrial enzymes to convert the XTT substrate into a soluble, colored formazan product (3), and there is a direct correlation between the number of live cells and the amount of product formed (5) . Therefore, because many small research programs like ours cannot afford expensive TNF-αELISA kits but still need a sensitive and reproducible TNF-αassay, we have modified and improved a TNF-αbioassay using the XTT substrate (Cell Proliferation Kit II; Boehringer Mannheim, Indianapolis, IN, USA) and purified TNF-αstandards (R & D Systems, Minneapolis, MN, USA). With the availability of World Health Organization (WHO) conversion tables for TNF -αunits, we also compared the sensitivity of our assay with a commercial TNF-αELISA.
